Pages that link to "Q40886474"
Jump to navigation
Jump to search
The following pages link to Cyclin D and oncogenesis (Q40886474):
Displayed 50 items.
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention (Q21245733) (← links)
- Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma (Q27824854) (← links)
- Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. (Q27851940) (← links)
- P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor (Q28143534) (← links)
- Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer (Q28167125) (← links)
- PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint (Q28298193) (← links)
- Requirement for cyclin D3 in lymphocyte development and T cell leukemias (Q28512456) (← links)
- Cyclins and cyclin-dependent kinases: a biochemical view (Q28611449) (← links)
- The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway (Q29615176) (← links)
- CycD1, a putative G1 cyclin from Antirrhinum majus, accelerates the cell cycle in cultured tobacco BY-2 cells by enhancing both G1/S entry and progression through S and G2 phases (Q33340320) (← links)
- Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells (Q33773096) (← links)
- Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes (Q33948380) (← links)
- NF-kappaB and cell-cycle regulation: the cyclin connection (Q34225148) (← links)
- Protein N-terminal acetyltransferases in cancer (Q34258775) (← links)
- Ras regulation of cyclin-dependent immunoprecipitation kinase assays (Q34278559) (← links)
- Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation (Q34478869) (← links)
- Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression (Q34565585) (← links)
- Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway (Q34647479) (← links)
- Identification of a novel vertebrate cyclin: cyclin B3 shares properties with both A- and B-type cyclins. (Q34729343) (← links)
- Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression (Q34786043) (← links)
- Linking cyclins to transcriptional control. (Q35012861) (← links)
- Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis (Q35094511) (← links)
- Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer. (Q35117351) (← links)
- Prevention of bronchial hyperplasia by EGFR pathway inhibitors in an organotypic culture model (Q35150980) (← links)
- Developmental regulation of CYCA2s contributes to tissue-specific proliferation in Arabidopsis (Q35178314) (← links)
- Targeting cell cycle regulators in hematologic malignancies. (Q35334436) (← links)
- Small-molecule cyclin-dependent kinase modulators (Q35551149) (← links)
- Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. (Q35643289) (← links)
- Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation (Q35854673) (← links)
- Systems biology and the molecular circuits of cancer (Q35905281) (← links)
- A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak (Q35960931) (← links)
- Prognosis of treatment response (pathological complete response) in breast cancer. (Q35971135) (← links)
- Cyclin D1 inactivation extends proliferation and alters histogenesis in the postnatal mouse retina (Q35993365) (← links)
- Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1. (Q36081485) (← links)
- Cyclin D3 predicts disease-free survival in breast cancer (Q36094615) (← links)
- Cyclins and cdks in development and cancer: a perspective (Q36101771) (← links)
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer (Q36134992) (← links)
- Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status (Q36136157) (← links)
- Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas (Q36138681) (← links)
- A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma (Q36191096) (← links)
- Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review (Q36238230) (← links)
- Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. (Q36568076) (← links)
- Role of cyclins in neuronal differentiation of immortalized hippocampal cells (Q36573600) (← links)
- Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma (Q36620193) (← links)
- Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB (Q36678011) (← links)
- Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression (Q36759552) (← links)
- A der(8)t(8;11) chromosome in the Karpas-620 myeloma cell line expresses only cyclin D1: yet both cyclin D1 and MYC are repositioned in close proximity to the 3'IGH enhancer (Q37184002) (← links)
- CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity (Q37586623) (← links)
- COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer (Q38290043) (← links)
- Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells (Q38360800) (← links)